Trials / Conditions / High-grade Serous Ovarian Cancer (HGSOC)
High-grade Serous Ovarian Cancer (HGSOC)
4 registered clinical trials studyying High-grade Serous Ovarian Cancer (HGSOC) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous NCT07432594 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Not Yet Recruiting | 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study NCT05956093 | University Health Network, Toronto | N/A |
| Recruiting | A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone NCT06188520 | AstraZeneca | Phase 1 / Phase 2 |
| Completed | Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer NCT06787170 | The First People's Hospital of Yunnan | — |